Status:
COMPLETED
Long-Term Specified Drug Use-results Survey of Betanis Tablets
Lead Sponsor:
Astellas Pharma Inc
Conditions:
Overactive Bladder
Eligibility:
All Genders
Brief Summary
This study is to evaluate the safety and efficacy of long-term use of Betanis (generic name: mirabegron), and to determine the adherence to treatment with mirabegron.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who administer mirabegron for treatment of urinary urgency, daytime frequency, and urgency incontinence associated with overactive bladder and also who have no treatment history of mirabegron.
Exclusion
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
1263 Patients enrolled
Trial Details
Trial ID
NCT01901120
Start Date
October 1 2012
End Date
September 1 2016
Last Update
November 1 2016
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Chūbu, Chubu, Japan
2
Chugoku, Chugoku, Japan
3
Hokkaido, Hokkaido, Japan
4
Kansai, Kansai, Japan